Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Fasenra receives positive EU CHMP opinion for self-administration and the new Fasenra pen, a pre-filled, single-use auto-injector
-
Imfinzi improves overall survival at interim analysis in the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
-
Breztri Aerosphere (PT010) approved in Japan for patients with chronic obstructive pulmonary disease
-
Lynparza approved in Japan for 1st-line maintenance therapy in BRCA-mutated advanced ovarian cancer
-
Bevespi Aerosphere approved by the Japanese Ministry of Health, Labour and Welfare for patients with chronic obstructive pulmonary disease
-
Lynparza approved in the EU for 1st-line maintenance treatment of BRCA-mutated advanced ovarian cancer
-
Calquence significantly prolonged the time patients lived without disease progression in relapsed or refractory chronic lymphocytic leukaemia
-
Lokelma demonstrated efficacy in treating hyperkalaemia in patients with end-stage renal disease on haemodialysis
-
Calquence Phase III ELEVATE-TN trial met primary endpoint at interim analysis in previously-untreated chronic lymphocytic leukaemia
-
Lynparza achieved a 72% objective response rate in patients with relapsed, germline BRCA-mutated advanced ovarian cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
